• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Broad Institute - Articles and news items


Broad Institute Genomic Services offers genomic insight into Ninlaro

Industry news / 25 January 2016 / Victoria White

Ninlaro (ixazomib) was recently approved by the FDA, indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +